Replimune Group Management
Management criteria checks 2/4
Replimune Group's CEO is Sush Patel, appointed in Apr 2024, has a tenure of less than a year. directly owns 0.084% of the company’s shares, worth $762.29K. The average tenure of the management team and the board of directors is 1.3 years and 6.6 years respectively.
Key information
Sush Patel
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.08% |
| Management average tenure | 1.3yrs |
| Board average tenure | 6.6yrs |
Recent management updates
Recent updates
Replimune: RPL1 BLA Submission Under AA Pathway Makes It A Must Watch
Nov 29Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Nov 23
Replimune: Strong Data In A Highly Differentiated Space
Sep 03Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?
Aug 16Replimune: Continuing To Justify The Bear Thesis (For Now)
May 22Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Feb 06Replimune: The Fall Is Justified, As Virus Therapy Fails Again In Cancer
Jan 23Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)
Dec 25Is Replimune Group (NASDAQ:REPL) A Risky Investment?
Jul 13Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?
Apr 05A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Jan 06Replimune secures $200M term loan
Oct 07Replimune: Recent Developments Strengthen Bull Thesis
Aug 12Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Aug 06Replimune Group GAAP EPS of -$0.78 misses by $0.15
Aug 04Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate
Jun 24We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate
Apr 04Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth
Dec 16Replimune: In The 'Buy Zone' Again
Oct 01Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Sep 02CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$213m |
| Jun 30 2024 | n/a | n/a | -US$220m |
| Mar 31 2024 | n/a | n/a | -US$216m |
| Dec 31 2023 | n/a | n/a | -US$210m |
| Sep 30 2023 | n/a | n/a | -US$199m |
| Jun 30 2023 | n/a | n/a | -US$182m |
| Mar 31 2023 | US$3m | US$447k | -US$174m |
| Dec 31 2022 | n/a | n/a | -US$157m |
| Sep 30 2022 | n/a | n/a | -US$147m |
| Jun 30 2022 | n/a | n/a | -US$133m |
| Mar 31 2022 | US$7m | US$394k | -US$118m |
Compensation vs Market: Insufficient data to establish whether Sush's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Sush's compensation has been consistent with company performance over the past year.
CEO
Sush Patel (53 yo)
less than a year
Tenure
US$2,595,003
Compensation
Dr. Sushil Patel, also known as Sush,Ph D, is CEO & Director of Replimune Group, Inc. from April 1, 2024. Dr. Patel served as the Chief Commercial Officer at Replimune Group, Inc. since May 3, 2021 and ser...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 10yrs | US$6.02m | 1.69% $ 15.4m | |
| Chief Financial Officer | 1.3yrs | US$3.61m | 0.016% $ 144.1k | |
| Chief Medical Officer | 2.1yrs | US$2.45m | 0.049% $ 447.7k | |
| CEO & Director | less than a year | US$2.60m | 0.084% $ 762.3k | |
| Founder | no data | US$5.72m | 2.33% $ 21.3m | |
| Chief Accounting Officer & Treasurer | 1.7yrs | no data | 0.0093% $ 84.9k | |
| Chief Commercial Officer | 2.1yrs | no data | 0.027% $ 247.6k | |
| Chief Manufacturing Officer & Framingham Site Head | less than a year | no data | no data |
1.3yrs
Average Tenure
53yo
Average Age
Experienced Management: REPL's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 10yrs | US$6.02m | 1.69% $ 15.4m | |
| CEO & Director | less than a year | US$2.60m | 0.084% $ 762.3k | |
| Founder | 10yrs | US$5.72m | 2.33% $ 21.3m | |
| Independent Director | 7.3yrs | US$362.60k | 0.0089% $ 80.7k | |
| Independent Non-Executive Director | 6.7yrs | US$355.10k | 0% $ 0 | |
| Independent Director | 4.8yrs | US$360.10k | 0% $ 0 | |
| Director | less than a year | no data | no data | |
| Independent Director | 7.5yrs | US$357.60k | 0% $ 0 | |
| Independent Director | 3.1yrs | US$352.60k | 0% $ 0 | |
| Lead Independent Director | 6.6yrs | US$516.81k | 0% $ 0 | |
| Independent Director | 1.6yrs | US$667.97k | 0% $ 0 |
6.6yrs
Average Tenure
59yo
Average Age
Experienced Board: REPL's board of directors are considered experienced (6.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 23:31 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Replimune Group, Inc. is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peter Lawson | Barclays |
| Clarence Powell | BMO Capital Markets Equity Research |
| Evan Seigerman | BMO Capital Markets Equity Research |